{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T16:37:06Z","timestamp":1762101426360,"version":"build-2065373602"},"reference-count":25,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[1994,1,1]],"date-time":"1994-01-01T00:00:00Z","timestamp":757382400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[1994,1,1]],"date-time":"1994-01-01T00:00:00Z","timestamp":757382400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[1994,1]]},"DOI":"10.1016\/s0002-9378(94)70391-4","type":"journal-article","created":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T06:12:08Z","timestamp":1367388728000},"page":"96-102","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Direct growth inhibition of human endometrial cancer cells by the gonadotropin-releasing hormone antagonist SB-75: Role of apoptosis"],"prefix":"10.1016","volume":"170","author":[{"given":"Dita","family":"Kleinman","sequence":"first","affiliation":[]},{"given":"Amos","family":"Douvdevani","sequence":"additional","affiliation":[]},{"given":"Andrew V.","family":"Schally","sequence":"additional","affiliation":[]},{"given":"Joseph","family":"Levy","sequence":"additional","affiliation":[]},{"given":"Yoav","family":"Sharoni","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S0002-9378(94)70391-4_bib1","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1111\/j.1471-0528.1991.tb15343.x","article-title":"A new treatment for endometrial cancer with gonadotrophin releasing-hormone analogue","volume":"98","author":"Gallagher","year":"1991","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/S0002-9378(94)70391-4_bib2","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1073\/pnas.79.5.1658","article-title":"Tumor growth inhibition in patients with prostatic carcinoma treated with luteinizing hormone\u2013releasing hormone agonists","volume":"79","author":"Tolis","year":"1982","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/S0002-9378(94)70391-4_bib3","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1210\/edrv-7-1-89","article-title":"Treatment of breast cancer with gonadotropin-releasing hormone","volume":"7","author":"Manni","year":"1986","journal-title":"Endocr Rev"},{"key":"10.1016\/S0002-9378(94)70391-4_bib4","first-page":"25","article-title":"New antagonistic analogues of LHRH: experimental oncological and clinical studies","author":"Schally","year":"1992"},{"key":"10.1016\/S0002-9378(94)70391-4_bib5","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1073\/pnas.89.6.2336","article-title":"Direct effects of luteinizing hormone-releasing hormone agonists and antagonists on MCF-7 mammary cancer cells","volume":"89","author":"Segal-Abramson","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/S0002-9378(94)70391-4_bib6","first-page":"314","article-title":"Direct antiproliferative effects of LH-RH analogues in cell lines of human epithelial ovarian cancer [Abstract]","author":"Emons","year":"1992"},{"key":"10.1016\/S0002-9378(94)70391-4_bib7","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/313231a0","article-title":"Growth of human breast cancer cells inhibited by a luteinizing hormone-releasing hormone agonist","volume":"313","author":"Miller","year":"1985","journal-title":"Nature"},{"key":"10.1016\/S0002-9378(94)70391-4_bib8","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/pros.2990140302","article-title":"Receptors for luteinizing hormone-releasing hormone, somatostatin, prolactin and epidermal growth factor in rat and human prostate cancers and in benign prostate hyperplasia","volume":"14","author":"Fekete","year":"1989","journal-title":"Prostate"},{"key":"10.1016\/S0002-9378(94)70391-4_bib9","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/00006676-198910000-00001","article-title":"Membrane receptors for peptides in experimental and human pancreatic cancers","volume":"4","author":"Fekete","year":"1989","journal-title":"Pancreas"},{"key":"10.1016\/S0002-9378(94)70391-4_bib10","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0028-2243(91)90091-X","article-title":"Specific low affinity binding sites for gonadotropin-releasing hormone in human endometrial carcinoma","volume":"41","author":"Pahwa","year":"1991","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/S0002-9378(94)70391-4_bib11","first-page":"1841","article-title":"Detection and partial characterization of receptors for [D -Trp6]-luteinizing hormone-releasing hormone and epidermal growth factor in human endometrial carcinoma","volume":"50","author":"Srkalovic","year":"1990","journal-title":"Cancer Res"},{"key":"10.1016\/S0002-9378(94)70391-4_bib12","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/0022-4731(87)91043-0","article-title":"Roles of antiestrogen binding sites in human endometrial cancer cells","volume":"26","author":"Hayashida","year":"1987","journal-title":"J Steroid Biochem"},{"key":"10.1016\/S0002-9378(94)70391-4_bib13","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/0002-9378(72)90861-7","article-title":"Establishment of a cell line of human endometrial adenocarcinoma in vitro","volume":"114","author":"Kuramoto","year":"1972","journal-title":"AM J OBSTET GYNECOL"},{"key":"10.1016\/S0002-9378(94)70391-4_bib14","first-page":"1103","article-title":"Establishment of a new human endometrial adenocarcinoma cell line, containing estrogen and progesterone receptors","volume":"37","author":"Nishida","year":"1985","journal-title":"Acta Obstet Gynaecol JPN"},{"key":"10.1016\/S0002-9378(94)70391-4_bib15","first-page":"936","article-title":"Evaluation of tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing","volume":"47","author":"Carmichael","year":"1987","journal-title":"Cancer Res"},{"key":"10.1016\/S0002-9378(94)70391-4_bib16","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/bjc.1989.341","article-title":"Effect of hormonal manipulation and doxorubucin administration on cell cycle kinetics of human breast cancer cells","volume":"60","author":"Bontenbal","year":"1989","journal-title":"Br J Cancer"},{"key":"10.1016\/S0002-9378(94)70391-4_bib17","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.4049\/jimmunol.139.10.3199","article-title":"Gene Induction by \u03b3-irradiation leads to DNA fragmentation in lymphocytes","volume":"139","author":"Sellins","year":"1987","journal-title":"J Immunol"},{"key":"10.1016\/S0002-9378(94)70391-4_bib18","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1073\/pnas.86.5.1648","article-title":"Inhibition of growth of human mammary tumor cells by potent antagonists of luteinizing hormone-releasing hormone","volume":"86","author":"Sharoni","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/S0002-9378(94)70391-4_bib19","first-page":"207","article-title":"Antiproliferative effects of luteinizing hormone-releasing hormone agonists on the human prostatic cancer cell line LNCaP","volume":"75","author":"Limonta","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S0002-9378(94)70391-4_bib20","first-page":"95","article-title":"Direct effects of GnRH agonists and antagonists on mammary cancer cells","author":"Sharoni","year":"1992"},{"key":"10.1016\/S0002-9378(94)70391-4_bib21","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1210\/edrv-11-3-443","article-title":"Uterine insulin-like growth factor-I: regulation of expression and its role in estrogen-induced uterine proliferation","volume":"11","author":"Murphy","year":"1990","journal-title":"Endocr Rev"},{"key":"10.1016\/S0002-9378(94)70391-4_bib22","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1038\/bjc.1991.203","article-title":"Growth inhibition observed following administration of an LHRH agonist to a clonal variant of the MCF-7 breast cancer cell line is accompanied by an accumulation of cells in the G0\/G1 phase of the cell cycle","volume":"63","author":"Mullen","year":"1991","journal-title":"Br J Cancer"},{"key":"10.1016\/S0002-9378(94)70391-4_bib23","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1093\/jnci\/82.6.513","article-title":"Growth inhibition of mouse MXT mammary tumor by the luteinizing hormone-releasing hormone antagonist SB-75","volume":"82","author":"Szende","year":"1990","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/S0002-9378(94)70391-4_bib24","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/pros.2990180307","article-title":"Histological changes in Dunning prostate tumors and testes of rats treated with LH-RH antagonist SB-75","volume":"18","author":"Szepeshazi","year":"1991","journal-title":"Prostate"},{"key":"10.1016\/S0002-9378(94)70391-4_bib25","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/ijc.2910490220","article-title":"Effect of combination treatment with analogs of luteinizing hormone-releasing hormone (LH-RH) or somatostatin and 5-fluorouracil on pancreatic cancer in hamsters","volume":"49","author":"Szepeshazi","year":"1991","journal-title":"Int J Cancer"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937894703914?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937894703914?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T10:01:39Z","timestamp":1757584899000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937894703914"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994,1]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1994,1]]}},"alternative-id":["S0002937894703914"],"URL":"https:\/\/doi.org\/10.1016\/s0002-9378(94)70391-4","relation":{},"ISSN":["0002-9378"],"issn-type":[{"type":"print","value":"0002-9378"}],"subject":[],"published":{"date-parts":[[1994,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Direct growth inhibition of human endometrial cancer cells by the gonadotropin-releasing hormone antagonist SB-75: Role of apoptosis","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S0002-9378(94)70391-4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1994 Published by Mosby, Inc.","name":"copyright","label":"Copyright"}]}}